Essential Facts on GP2B3A Inhibitors

Oct 12, 2024

GP2B3A Inhibitors: Key Facts for NCLEX

Introduction to GP2B3A Inhibitors

  • Drug Class: Blood thinners
  • Medications: Abciximab, Tyrophaban, Eptifibetide
  • Function: Target and block glycoprotein 2B3A on platelets
    • Role of GP2B3A: Involved in platelet plug formation for blood clots

Memory Aids

  • Mnemonic Device: Mario Kart Grand Prix on lap 2 out of 3 for GP2B3A
  • Drug Name Mnemonics:
    • Abciximab: ABC blocks
    • Tyrophaban: Tyrannosaurus in Mario Kart
    • Eptifibetide: Epitaph for Eptifibetide

Mechanism of Action

  • Action: Prevents platelet function by blocking their clumping
  • Analogy: Paint thinner preventing clumpy paint
    • Relation to Drugs: Abciximab and others act as blood thinners

Clinical Uses

  • Prevention of Clots:
    • During coronary artery stenting
    • In coronary emergencies (unstable angina, myocardial infarctions)

Side Effects

  • Main Side Effect: Bleeding
    • Signs of Bleeding: Hypotension, tachycardia, tarry stools, blood in urine
    • Patient Care: Avoid invasive procedures; monitor hemoglobin and RBC levels

Conclusion

  • Summary: GP2B3A inhibitors are antiplatelet agents used to prevent clots but can cause bleeding.
    • Monitoring: Keep track of CBC levels and signs of bleeding
  • Resources: Subscribe for more videos and check out additional resources for interactive learning.